Evolution of interstitial lung disease one year after hematopoietic stem cell transplantation or cyclophosphamide for systemic sclerosis.
Jacopo CiaffiNina Marijn van LeeuwenMaaike BoonstraLucia J M KroftAnne A SchouffoerMaarten K NinaberTom W J HuizingaJeska K de Vries-BouwstraPublished in: Arthritis care & research (2020)
One year after treatment with HSCT, a non-significant, but clear, reduction of SSc-ILD extent was observed. Changes in PFTs were associated with changes in HRCT scores but the correlation was weak and cannot be considered conclusive.